Clinical Trial Update: First in Human Study of EMB-07 in Locally Advanced/Metastatic Solid Tumors or Relapse/Refractory Lymphoma [Phase 1]

View source ↗

Summary

First-in-human Phase 1 study of EMB-07 in patients with advanced/metastatic solid tumors or relapsed/refractory lymphoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Solid Tumors

Drugs mentioned

• EMB-07 (EMB-07)

Snippet

Sponsor: EpimAb Biotherapeutics (Suzhou)Co., Ltd. | Conditions: Advanced/Metastatic Solid Tumors, Relapse/Refractory Lymphoma | Phase 1 | Status: RECRUITING